2011
DOI: 10.1016/s1773-2247(11)50006-1
|View full text |Cite
|
Sign up to set email alerts
|

Lecithin-based nanoemulsions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
88
0
17

Year Published

2015
2015
2024
2024

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 189 publications
(121 citation statements)
references
References 154 publications
1
88
0
17
Order By: Relevance
“…Generally, it was expected that the incorporation of DZM into nanoemulsion would enlarge the droplet size, since additional lipophilic molecules need to be solubilized in the oil phase [1]. However, the obtained results also imply a possible interaction between DZM and emulsifier layer and, consequently, partial drug localization in the o/w interface leading to the reduction of the surface tension and therefore the droplet size, during the homogenization step [11,19].…”
Section: Resultsmentioning
confidence: 89%
See 2 more Smart Citations
“…Generally, it was expected that the incorporation of DZM into nanoemulsion would enlarge the droplet size, since additional lipophilic molecules need to be solubilized in the oil phase [1]. However, the obtained results also imply a possible interaction between DZM and emulsifier layer and, consequently, partial drug localization in the o/w interface leading to the reduction of the surface tension and therefore the droplet size, during the homogenization step [11,19].…”
Section: Resultsmentioning
confidence: 89%
“…Concerning the oil phase, MCT and SO, as the most widely used oils in the commercially available parenteral lipid emulsions [1,14] were selected, whereas lecithin and polysorbate 80 were used as emulsifiers for the nanoemulsion preparation. The oil-emulsifier ratio was kept constant at 5:1 (w/w) in all formulations.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Dodatno, poboljšana penetracija kroz biološke barijere, povećanje biološke raspoloživosti, smanjenje iritacije i/ili toksičnosti, produženo oslobađanje i ciljna isporuka lekovite supstance u različite organe mogu se očekivati nakon primene nanoemulzionih sistema (4)(5)(6). Na osnovu navedenih činjenica, ne iznenađuje da nanoemulzije predstavljaju privlačnu alternativu za savladavanje krvnomoždane barijere i poboljšanu isporuku slabo rastvorljivih psihofarmakoloških lekovitih supstanci (kakav je diazepam) u mozak, parenteralnim putem, naročito u urgentnim stanjima i kada postoje problemi sa gutanjem.…”
Section: Lekovita Supstancaunclassified
“…U skladu sa načinom primene, parenteralne nanoemulzije izrađuju se iz visoko bezbednih i biokompatibilnih ulja (sojino, trigliceridi srednje dužine lanca, suncokretovo, maslinovo, riblje) i emulgatora (fosfolipidi, polisorbati, poloksameri), najčešće metodom homogenizacije pod visokim pritiskom (6,7). Komercijalno dostupni preparati nanoemulzija uglavnom sadrže 10 ili 20% uljane faze; povećanje udela ulja omogućilo bi inkorporiranje veće količine liposolubilne lekovite supstance, a otuda i smanjenje volumena injektovanja ili infuzije.…”
Section: Lekovita Supstancaunclassified